Analystreport

Outlook Therapeutics, Inc. (NASDAQ: OTLK) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Outlook Therapeutics, Inc.  (OTLK) 
Last outlook therapeutics, inc. earnings: 2/14 08:00 am Check Earnings Report